Excessive Daytime Sleepiness Is Associated with Changes in Salivary Inflammatory Genes Transcripts

Table 5

Comparison of transcriptional changes in high and low BMI subjects.

Gene	Abbreviation	BMI < 30	BMI > 30	-test
		fold	fold
-actin	ACTB	1.39 ± 0.29	1.65 ± 0.40	0.438
Arachidonate 5-lipoxygenase	ALOX5	1.46 ± 0.33	0.97 ± 0.28	0.117
Arachidonate 12-lipoxygenase	ALOX12	1.25 ± 0.47	0.48 ± 0.32	0.058
Annexin A1	ANXA1	3.06 ± 1.25	2.33 ± 1.03	0.529
Annexin A3	ANXA3	1.68 ± 0.40	1.63 ± 0.61	0.913
Annexin A5	ANXA5	1.74 ± 0.58	2.17 ± 0.75	0.519
-2-microglobulin	B2M	1.95 ± 0.66	3.12 ± 0.91	0.156
Caspase 1, apoptosis-related cysteine peptidase	CASP1	2.68 ± 0.90	3.05 ± 1.42	0.741
Glyceraldehyde-3-phosphate dehydrogenase	GAPDH	2.14 ± 0.72	1.94 ± 0.57	0.771
Intercellular adhesion molecule 1	ICAM1	0.61 ± 0.22	0.62 ± 0.36	0.982
Interleukin 1 receptor, type II	IL1R2	1.88 ± 0.53	1.24 ± 0.34	0.153
Interleukin 2 receptor, gamma	IL2RG	2.65 ± 1.37	2.20 ± 0.93	0.713
Integrin, alpha M	ITGAM	1.56 ± 0.48	1.25 ± 0.51	0.537
Integrin, beta 2	ITGB2	1.52 ± 0.35	1.54 ± 0.38	0.949
Mitogen-activated protein kinase 1	MAPK1	1.77 ± 0.83	1.20 ± 0.37	0.355
Mitogen-activated protein kinase 3	MAPK3	1.41 ± 0.36	0.90 ± 0.34	0.156
Mitogen-activated protein kinase 14	MAPK14	2.18 ± 0.60	1.51 ± 0.45	0.211
Phosphodiesterase 4B, cAMP-specific	PDE4B	1.44 ± 0.36	1.44 ± 0.55	0.999
Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)	PTGS2	2.43 ± 0.84	3.42 ± 1.13	0.338
Tumor necrosis factor receptor superfamily, member 1A	TNFRSF1A	1.47 ± 0.36	1.40 ± 0.33	0.841
Tumor necrosis factor receptor superfamily, member 1B	TNFRSF1B	1.72 ± 0.66	0.86 ± 0.36	0.099

Mean ± SEM.
= 15–24.
= 11–15.